Insider · SEC Form 4 filer

Jeffrey Brown

Past buys: 1 of 10 beat

Companies

Where they file as an insider

Upbound Group (UPBD) Director Latest filing Nov 2, 2026
Medifast (MED) Director Latest filing Jun 25, 2025

Track record

Did their buys beat the typical stock?

Open-market buys23
Quarters checked 6 months later10
Beat the typical stock 1 of 10
Quarters too new to check3

1 of 10 checked quarters beat the typical stock. A past record is data, not a forecast.

Upbound Group (UPBD) Bought Oct 27–Nov 2, 2026 · $447K · 20,409 shares Too new Too new. Its 6-month check uses prices as of Jun 30, 2027.
Upbound Group (UPBD) Bought Jul 7, 2026 · $46.1K · 2,295 shares Too new Too new. Its 6-month check uses prices as of Mar 31, 2027.
Upbound Group (UPBD) Bought Apr 28, 2026 · $45.2K · 2,329 shares Too new Too new. Its 6-month check uses prices as of Dec 31, 2026.
Upbound Group (UPBD) Bought Jan 6, 2026 · $44.2K · 2,502 shares Behind typical Mar 31, 2026 $18.05 → Sep 30, 2026 $15.70 · −13.0% (typical stock +1.7%)
Upbound Group (UPBD) Bought Oct 21, 2025 · $43.4K · 1,951 shares Beat typical Dec 31, 2025 $17.56 → Jun 30, 2026 $21.22 · +20.8% (typical stock +4.7%)
Upbound Group (UPBD) Bought Jul 8, 2025 · $42.8K · 1,653 shares Behind typical Sep 30, 2025 $23.63 → Mar 31, 2026 $18.05 · −23.6% (typical stock −3.4%)
Upbound Group (UPBD) Bought Apr 22–May 6, 2025 · $550K · 23,424 shares Behind typical Jun 30, 2025 $25.10 → Dec 31, 2025 $17.56 · −30.0% (typical stock +2.1%)
Upbound Group (UPBD) Bought Jan 7, 2025 · $33.2K · 1,146 shares Behind typical Mar 31, 2025 $23.96 → Sep 30, 2025 $23.63 · −1.4% (typical stock +7.3%)
Upbound Group (UPBD) Bought Oct 22, 2024 · $31.2K · 1,065 shares Behind typical Dec 31, 2024 $29.17 → Jun 30, 2025 $25.10 · −14.0% (typical stock −3.4%)
Upbound Group (UPBD) Bought Jul 9, 2024 · $30.7K · 1,031 shares Behind typical Sep 30, 2024 $31.99 → Mar 31, 2025 $23.96 · −25.1% (typical stock −7.5%)
Upbound Group (UPBD) Bought Apr 22, 2024 · $30.4K · 991 shares Behind typical Jun 30, 2024 $30.70 → Dec 31, 2024 $29.17 · −5.0% (typical stock +3.9%)
Upbound Group (UPBD) Bought Jan 9, 2024 · $30K · 912 shares Behind typical Mar 31, 2024 $35.21 → Sep 30, 2024 $31.99 · −9.1% (typical stock +3.2%)
Medifast (MED) Bought Nov 3–7, 2023 · $10.8K · 155 shares Not counted Not counted. We have no fund price for this stock on both Dec 31, 2023 and Jun 30, 2024.
Upbound Group (UPBD) Bought Oct 24, 2023 · $27.3K · 988 shares Behind typical Dec 31, 2023 $33.97 → Jun 30, 2024 $30.70 · −9.6% (typical stock −1.2%)

Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.

Past results. This is data, not advice.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist